Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 28, 2016; 22(4): 1664-1673
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1664
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1664
Etiologies of fatty liver disease |
Frequent causes: |
Non-alcoholic fatty liver disease |
Alcoholic fatty liver disease |
Chronic hepatitis C virus infection |
Drug-induced steatosis |
Less common or rare causes: |
Inborn errors of metabolism (Wilson disease, abetalipoproteinemia, tyrosinaemia, hypobetalipoproteinemia) |
Lipodystrophy (congenital or acquired) |
Total parenteral nutrition |
Surgical procedures (e.g., biliopancreatic diversion extensive small bowel resection) |
Causes of drug-induced fatty liver disease |
Predominantly microvesicular pattern: |
Tetracyclin |
Valproic acid |
Amiodarone |
Glucocorticoids |
5-FU |
Margosa oil |
Predominantly macrovesicular pattern: |
Acetylsalicylic acid (intoxication) |
Tamoxifen |
Mixed pattern: |
Antiretroviral agents (e.g., didanosine, stavudine) |
Methotrexate |
- Citation: Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol 2016; 22(4): 1664-1673
- URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1664.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1664